Swedish Orphan Biovitrum AB (SOBIN) Revenue
Swedish Orphan Biovitrum AB Revenue
Swedish Orphan Biovitrum AB had a revenue of 9.12B in the quarter ending Sep 30, 2026, with 16.35%. This bring the company's revenue in the last twelve months to 31.97B, Increased 4.40%. In the fiscal year ending Dec 31, 2025, Swedish Orphan Biovitrum AB had annual revenue of 28.24B with 8.50% growth.
- Revenue (ttm)
- 31.97B
- Revenue Growth
- 11.11%
- P/S Ratio
- 11.46
- Revenue/Employee
- MXN 13,326,097
- Employees
- 2,119
- Market Cap
- MXN 323.71B
Revenue Chart
Swedish Orphan Biovitrum AB Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 28.24B | 2.21B | 8.50% |
| Dec 31, 2024 | 26.03B | 3.90B | 17.65% |
| Dec 31, 2023 | 22.12B | 3.33B | 17.74% |
| Dec 31, 2022 | 18.79B | 3.26B | 21.00% |
| Dec 31, 2021 | 15.53B | 268.00M | 1.76% |
| Dec 31, 2020 | 15.26B | 1.01B | 7.11% |
| Dec 31, 2019 | 14.25B | 5.11B | 55.91% |
| Dec 31, 2018 | 9.14B | 2.63B | 40.36% |
| Dec 31, 2017 | 6.51B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.